Ticker Details
Phathom Pharmaceuticals, Inc.
IPO Date:	October 21, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$961.86M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.64 | 3.81%
Avg Daily Range (30 D):	$0.31 | 2.92%
Avg Daily Range (90 D):	$0.34 | 3.03%

Institutional Daily Volume
Avg Daily Volume:	.51M
Avg Daily Volume (30 D):	.97M
Avg Daily Volume (90 D):	1.02M

Trade Size
Avg Trade Size (Sh.):	88
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	1,069
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$1.2M
Avg Institutional Trade (90 D):	$1.21M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.41M
Avg Closing Trade (30 D):	$1.43M
Avg Closing Trade (90 D):	$1.45M
Avg Closing Volume:	105.74K

News

May 1, 2026 @ 12:00 PM Phathom Pharmaceuticals to Highlight VOQUEZNA® ... Source: Phathom Pharmaceuticals, Inc.

Apr 13, 2026 @ 5:00 PM Eosinophilic Esophagitis Market in the US to Grow ... Source: Delveinsight

Jan 8, 2026 @ 1:41 PM Stock Market Today: S&P 500, Dow Jones, Nasdaq 100... Source: Rishabh Mishra

Jan 8, 2026 @ 3:33 AM Phathom Pharmaceuticals Announces Pricing of $130 ... Source: Na

Oct 23, 2025 @ 12:00 PM Phathom Pharmaceuticals to Highlight VOQUEZNA® ... Source: Phathom Pharmaceuticals

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.03	$-.27	$-3.03
Diluted EPS	$-3.03	$-.27	$-3.03
Revenue	$175.11M	$57.58M	$175.11M
Gross Profit	$152.51M	$49.94M	$152.51M
Net Income / Loss	$-221.25M	$-21.15M	$-221.25M
Operating Income / Loss	$-159.99M	$-5.93M	$-159.99M
Cost of Revenue	$22.6M	$7.65M	$22.6M
Net Cash Flow	$-167.29M	$-5.19M	$-167.29M
PE Ratio